Volume 17, Issue 2 670153 pp. e24-e26
Open Access

Piperacillin-Associated Pulmonary Infiltrates with Eosinophilia: A Case Report

Olivia Ling-I Tseng

Olivia Ling-I Tseng

Department of Internal Medicine St Paul’s Hospital University of British Columbia Vancouver British Columbia, Canada , ubc.ca

Search for more papers by this author
John Thomas Kelsall

Corresponding Author

John Thomas Kelsall

Department of Internal Medicine St Paul’s Hospital University of British Columbia Vancouver British Columbia, Canada , ubc.ca

Search for more papers by this author
Pearce George Wilcox

Pearce George Wilcox

Department of Internal Medicine St Paul’s Hospital University of British Columbia Vancouver British Columbia, Canada , ubc.ca

Search for more papers by this author
First published: 01 January 2010
Citations: 5

Abstract

A case of pulmonary infiltrates with eosinophilia attributed to piperacillin/tazobactam therapy is described. A 54-year-old woman was treated for a suspected severe urinary tract infection with piperacillin/tazobactam. Four days later, she developed fever, chills, shortness of breath and intermittent chest pains. Eosinophilia was noted in peripheral blood and, subsequently, on bronchoalveolar lavage. Transbronchial biopsy showed tissue infiltrates with eosinophilia. No evidence of bacterial, fungal and parasitic infection, or vasculitis was observed. Her symptoms and peripheral eosinophilia subsided after drug discontinuation and oral prednisone treatment. Piperacillin is an extended-spectrum penicillin antibiotic prescribed for moderate to severe infections. The common adverse reactions to piperacillin include nausea, vomiting, diarrhea and rash. Pulmonary infiltrates with eosinophilia is a rare adverse reaction, but one that may result in significant morbidity. Physicians should be aware of this rare but important adverse reaction to piperacillin.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.